I refer to previous correspondence concerning the potential for human health effects of the proposed widespread release of rabbit calicivirus (RCV). You will recall my initial advice provided to you on 12 March 1996 expressed a heavily qualified opinion, that in light of the available information, RCV was unlikely to pose a significant threat to human health.

Since that time you will be aware that a human health study has been undertaken on a group of 269 people,159 of which had been occupationally exposed to rabbits infected with RCV. The study sought evidence of clinical effects or measurable specific antibody responses in humans attributable to exposure to RCV within the preceding 12 months. No serological evidence of human infection with RCV was obtained. In addition, there was also no detectable temporal association between exposure to RCV and incidents of clinical illness. Reports from laboratories and people working with RCV overseas have also indicated a lack of clinical effects associated with exposure to RCV.